Attached files
file | filename |
---|---|
EX-32.1 - EX-32.1 - Larimar Therapeutics, Inc. | lrmr-ex321_6.htm |
EX-31.2 - EX-31.2 - Larimar Therapeutics, Inc. | lrmr-ex312_8.htm |
EX-31.1 - EX-31.1 - Larimar Therapeutics, Inc. | lrmr-ex311_7.htm |
EX-23.1 - EX-23.1 - Larimar Therapeutics, Inc. | lrmr-ex231_673.htm |
EX-4.2 - EX-4.2 - Larimar Therapeutics, Inc. | lrmr-ex42_407.htm |
10-K - 10-K - Larimar Therapeutics, Inc. | lrmr-10k_20201231.htm |
Exhibit 21.1
LIST OF SUBSIDIARIES
Subsidiary |
Ownership Percentage |
Jurisdiction of Incorporation or Organization |
Zafgen Australia Pty Ltd. |
100% |
Australia |
Chondrial Therapeutics IP, LLC |
100% |
Delaware |
Zafgen Securities Corp. |
100% |
Massachusetts |
Zafgen Animal Health, LLC |
100% |
Delaware |